Mythic Therapeutics, Inc. — Form D
Mythic Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-14. The offering totals $18.8M, of which $18.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-14
- Form: D
- Accession: 0001819730-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.8M
- Amount sold: $18.8M
- Investors: 18
- Date of first sale: 2020-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-373217
Issuer
- Name: Mythic Therapeutics, Inc.
- CIK: 0001819730
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 100 BEAVER ST., STE 303, WALTHAM, MA, 02453
- Phone: 617-917-4638
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jason Hanson | Director | Waltham, MA |
| Josh Kopelman | Director | Philadelphia, PA |
| George Eliades | Director | Waltham, MA |
| George Eliades | Executive Officer | Waltham, MA |
| Bryan Roberts | Director | Boulder, CO |
| Peter Hecht | Director | Waltham, MA |
| Sandra Poole | Executive Officer | Waltham, MA |
| Brian Fiske | Director | Waltham, MA |
| Brian Fiske | Executive Officer | Waltham, MA |
| Brian Fiske | Promoter | Waltham, MA |
| Alex Nichols | Director | Waltham, MA |
| Alex Nichols | Executive Officer | Waltham, MA |
| Alex Nichols | Promoter | Waltham, MA |
Other filings by this issuer (2)
More